金城醫藥(300233.SZ)解除與關聯方昂遠地產的房產銷售合同協議書
格隆匯12月30日丨金城醫藥(300233.SZ)公佈,2019年12月30日,公司召開第四屆董事會第二十六次會議,審議通過了關於《簽署
<解除房產銷售合同協議書>
暨關聯交易》的議案。
解除房產銷售合同協議書>
公司於2019年1月14日召開第四屆董事會第十九次會議,審議通過《關於購買房產暨關聯交易的議案》,同意公司購買關聯方淄博昂遠創新產業發展有限公司(“昂遠地產”)位於山東省淄博市淄博經濟開發區蘇袁路以東、淄博潤義金有限公司以南創新產業園二期部分房產,面積共計5998.88平方米,交易金額為2519.5196萬元。
昂遠地產系山東金城榮基地產有限公司全資子公司(“榮基地產”),榮基地產系公司實際控制人趙鴻富的配偶控制的公司,根據《深圳證券交易所創業板股票上市規則》的規定,昂遠地產為公司關聯法人。此次交易構成關聯交易。
此次交易解除主要系該房產建成交付後無法辦理產權登記證書。為維護公司利益,本着謹慎原則,公司董事會認為解除相關協議,收回已支付款項,更有利於公司的後續發展。交易解除後對公司本期和未來財務狀況和經營成果不會構成重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.